These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27922666)

  • 41. Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells.
    Kittaka M; Shiba H; Kajiya M; Ouhara K; Takeda K; Kanbara K; Fujita T; Kawaguchi H; Komatsuzawa H; Kurihara H
    J Periodontal Res; 2013 Apr; 48(2):228-34. PubMed ID: 22943069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer.
    Gill K; Mohanti BK; Singh AK; Mishra B; Dey S
    Cancer Biomark; 2011-2012; 10(3-4):125-34. PubMed ID: 22674298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Y-box-binding protein 1 (YB-1) and its functions.
    Eliseeva IA; Kim ER; Guryanov SG; Ovchinnikov LP; Lyabin DN
    Biochemistry (Mosc); 2011 Dec; 76(13):1402-33. PubMed ID: 22339596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. YB-1, the E2F pathway, and regulation of tumor cell growth.
    Lasham A; Samuel W; Cao H; Patel R; Mehta R; Stern JL; Reid G; Woolley AG; Miller LD; Black MA; Shelling AN; Print CG; Braithwaite AW
    J Natl Cancer Inst; 2012 Jan; 104(2):133-46. PubMed ID: 22205655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor.
    Girnita A; Zheng H; Grönberg A; Girnita L; Ståhle M
    Oncogene; 2012 Jan; 31(3):352-65. PubMed ID: 21685939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma.
    Kim JE; Kim HJ; Choi JM; Lee KH; Kim TY; Cho BK; Jung JY; Chung KY; Cho D; Park HJ
    Br J Dermatol; 2010 Nov; 163(5):959-67. PubMed ID: 20977442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LL-37 as a therapeutic target for late stage prostate cancer.
    Hensel JA; Chanda D; Kumar S; Sawant A; Grizzle WE; Siegal GP; Ponnazhagan S
    Prostate; 2011 May; 71(6):659-70. PubMed ID: 20957672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.
    Wu WK; Wang G; Coffelt SB; Betancourt AM; Lee CW; Fan D; Wu K; Yu J; Sung JJ; Cho CH
    Int J Cancer; 2010 Oct; 127(8):1741-7. PubMed ID: 20521250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance.
    Shiota M; Yokomizo A; Tada Y; Uchiumi T; Inokuchi J; Tatsugami K; Kuroiwa K; Yamamoto K; Seki N; Naito S
    Cancer Sci; 2010 Aug; 101(8):1797-806. PubMed ID: 20491776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Y-box binding protein-1 is a novel molecular target for tumor vessels.
    Takahashi M; Shimajiri S; Izumi H; Hirano G; Kashiwagi E; Yasuniwa Y; Wu Y; Han B; Akiyama M; Nishizawa S; Sasaguri Y; Kohno K
    Cancer Sci; 2010 Jun; 101(6):1367-73. PubMed ID: 20398058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway.
    Pistolic J; Cosseau C; Li Y; Yu JJ; Filewod NC; Gellatly S; Rehaume LM; Bowdish DM; Hancock RE
    J Innate Immun; 2009; 1(3):254-67. PubMed ID: 20375583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cathelicidin LL-37: a multitask antimicrobial peptide.
    Bucki R; Leszczyńska K; Namiot A; Sokołowski W
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):15-25. PubMed ID: 20049649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
    Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
    Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer.
    Chuang CM; Monie A; Wu A; Mao CP; Hung CF
    Hum Gene Ther; 2009 Apr; 20(4):303-13. PubMed ID: 19272013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.
    Coffelt SB; Marini FC; Watson K; Zwezdaryk KJ; Dembinski JL; LaMarca HL; Tomchuck SL; Honer zu Bentrup K; Danka ES; Henkle SL; Scandurro AB
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3806-11. PubMed ID: 19234121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer.
    Weber G; Chamorro CI; Granath F; Liljegren A; Zreika S; Saidak Z; Sandstedt B; Rotstein S; Mentaverri R; Sánchez F; Pivarcsi A; Ståhle M
    Breast Cancer Res; 2009; 11(1):R6. PubMed ID: 19183447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumors sound the alarmin(s).
    Coffelt SB; Scandurro AB
    Cancer Res; 2008 Aug; 68(16):6482-5. PubMed ID: 18701469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
    Guay D; Garand C; Reddy S; Schmutte C; Lebel M
    Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twist promotes tumor cell growth through YB-1 expression.
    Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
    Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.
    Coffelt SB; Waterman RS; Florez L; Höner zu Bentrup K; Zwezdaryk KJ; Tomchuck SL; LaMarca HL; Danka ES; Morris CA; Scandurro AB
    Int J Cancer; 2008 Mar; 122(5):1030-9. PubMed ID: 17960624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.